Almotriptan
Overview
Categories
- 7 Antimigraine preparations
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Almotriptan's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 6.25 mg/day | 6.2 (6.25) | As recommended. | PO | In patients with hepatic impairment the maximum daily dose should not exceed 12.5 mg over a 24-hour period. |
| 6.25 to 12.5 mg/day | 9.4 (9.375) | As recommended. | PO | If the headache is relieved after the initial dose but returns, the dose may be repeated after 2 hours. The effectiveness of a second dose has not been established in placebo-controlled trials. The maximum daily dose should not exceed 25 mg. The safety of treating an average of more than four migraines in a 30-day period has not been established. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Almotriptan is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Almotriptan is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Almotriptan
Back to top
Previous Drug Generic - Next Drug Generic